Liver Sinusoidal Endothelial Cells Are a Site of Murine Cytomegalovirus Latency and Reactivation
- 1 September 2009
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 83 (17), 8869-8884
- https://doi.org/10.1128/jvi.00870-09
Abstract
Latent cytomegalovirus (CMV) is frequently transmitted by organ transplantation, and its reactivation under conditions of immunosuppressive prophylaxis against graft rejection by host-versus-graft disease bears a risk of graft failure due to viral pathogenesis. CMV is the most common cause of infection following liver transplantation. Although hematopoietic cells of the myeloid lineage are a recognized source of latent CMV, the cellular sites of latency in the liver are not comprehensively typed. Here we have used the BALB/c mouse model of murine CMV infection to identify latently infected hepatic cell types. We performed sex-mismatched bone marrow transplantation with male donors and female recipients to generate latently infected sex chromosome chimeras, allowing us to distinguish between Y-chromosome (gene sry or tdy)-positive donor-derived hematopoietic descendants and Y-chromosome-negative cells of recipients' tissues. The viral genome was found to localize primarily to sry-negative CD11b(-) CD11c(-) CD31(+) CD146(+) cells lacking major histocompatibility complex class II antigen (MHC-II) but expressing murine L-SIGN. This cell surface phenotype is typical of liver sinusoidal endothelial cells (LSECs). Notably, sry-positive CD146(+) cells were distinguished by the expression of MHC-II and did not harbor latent viral DNA. In this model, the frequency of latently infected cells was found to be 1 to 2 per 10(4) LSECs, with an average copy number of 9 (range, 4 to 17) viral genomes. Ex vivo-isolated, latently infected LSECs expressed the viral genes m123/ie1 and M122/ie3 but not M112-M113/e1, M55/gB, or M86/MCP. Importantly, in an LSEC transfer model, infectious virus reactivated from recipients' tissue explants with an incidence of one reactivation per 1,000 viral-genome-carrying LSECs. These findings identified LSECs as the main cellular site of murine CMV latency and reactivation in the liver.Keywords
This publication has 158 references indexed in Scilit:
- The Mouse Cytomegalovirus Immediate-Early 1 Gene Is Not Required for Establishment of Latency or for Reactivation in the LungsJournal of Virology, 2009
- Transactivation of Cellular Genes Involved in Nucleotide Metabolism by the Regulatory IE1 Protein of Murine Cytomegalovirus Is Not Critical for Viral Replicative Fitness in Quiescent Cells and Host TissuesJournal of Virology, 2008
- Hematopoietic stem cell transplantation with latently infected donors does not transmit virus to immunocompromised recipients in the murine model of cytomegalovirus infectionMedical Microbiology and Immunology, 2008
- Murine CD146 is widely expressed on endothelial cells and is recognized by the monoclonal antibody ME-9F1Histochemistry and Cell Biology, 2008
- Human Cytomegalovirus Tropism for Endothelial Cells: Not All Endothelial Cells Are Created EqualJournal of Virology, 2007
- CD8 T Cells Control Cytomegalovirus Latency by Epitope-Specific Sensing of Transcriptional ReactivationJournal of Virology, 2006
- Hepatic targeting of transplanted liver sinusoidal endothelial cells in intact miceJournal of Hepatology, 2005
- CMV Infection of transplant RecipientsJournal of Hepatology, 1996
- Molecular and functional aspects of PECAM-1/CD31Immunology Today, 1994
- Regulation of MHC Class II Expression by Interferon-γ Mediated by the Transactivator Gene CIITAScience, 1994